Gallium(III) complexes with 2-acetylpyridine-derived thiosemicarbazones: antimicrobial and cytotoxic effects and investigation on the interactions with tubulin

Complexes [Ga(2Ac4pFPh)₂]NO₃ (1), [Ga(2Ac4pClPh)₂]NO₃ (2), [Ga(2Ac4pIPh)₂]NO₃ (3), [Ga(2Ac4pNO₂Ph)₂]NO₃·3H₂O (4) and [Ga(2Ac4pT)₂]NO₃ (5) were obtained with 2-acetylpyridine N(4)-para-fluorophenyl-(H2Ac4pFPh), 2-acetylpyridine N(4)-para-chlorophenyl-(H2Ac4pClPh), 2-acetylpyridine N(4)-para-iodophenyl-(H2Ac4pIPh), 2-acetylpyridine N(4)-para-nitrophenyl-(H2Ac4pNO₂Ph) and 2-acetylpyridine N(4)-para-tolyl-(H2Ac4pT) thiosemicarbazone. 1–5 presented antimicrobial and cytotoxic properties. Coordination to gallium(III) proved to be an effective strategy for activity improvement against Pseudomonas aeruginosa and Candida albicans. The complexes were highly cytotoxic against malignant glioblastoma and breast cancer cells at nanomolar concentrations. The compounds induced morphological changes characteristic of apoptotic death in tumor cells and showed no toxicity against erythrocytes. 2 partially inhibited tubulin assembly at high concentrations and induced cellular microtubule disorganization, but this does not appear to be the main mechanism of cytotoxic activity.     

Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity

Complexes [Au(H2Ac4DH)Cl]?MeOH (1) [Au(H₂2Ac4Me)Cl]Cl (2) [Au(H₂2Ac4Ph)Cl]Cl?2H₂O (3) and [Au(H₂2Bz4Ph)Cl]Cl (4) were obtained with 2-acetylpyridine thiosemicarbazone (H2Ac4DH), its N(4)-methyl (H2Ac4Me) and N(4)-phenyl (H2Ac4Ph) derivatives, as well as with N(4)-phenyl 2-benzoylpyridine thiosemicarbazone (H2Bz4Ph). The compounds were cytotoxic to Jurkat (immortalized line of T lymphocyte), HL-60 (acute myeloid leukemia), MCF-7 (human breast adenocarcinoma) and HCT-116 (colorectal carcinoma) tumor cell lines. Jurkat and HL-60 cells were more sensitive than MCF-7 and HCT-116 cells. Upon coordinating to the gold(I) metal centers in complexes (2) and (4), the cytotoxic activity of the H2Ac4Me and H2Bz4Ph ligands increased against the HL-60 and Jurkat tumor cell lines. 2 was more active than auranofin against both leukemia cells. Most of the studied compounds were less toxic than auranofin to peripheral blood mononuclear cells (PBMC). All compounds induced DNA fragmentation in HL-60 and Jurkat cells indicating their pro-apoptotic potential. Complex (2) strongly inhibited the activity of thioredoxin reductase (TrxR), which suggests inhibition of TrxR to be part of its mechanism of action.     

Influence of the phosphine arrangement on the reactivity of palladium(II) and platinum(II) polyphosphine complexes with copper(I) chloride

The distorted square-planar complexes [Pd(PNHP)Cl]Cl (1) (PNHP = bis[2-(diphenylphosphino)ethyl]amine), [M(P₃)Cl]Cl [P₃ = bis[2-(diphenylphosphino)ethyl]phenylphosphine; M = Pd (2), Pt (3)] and [Pt(NP₃)Cl]Cl (5) (NP₃ = tris[2-(diphenylphosphino)ethyl]amine), coexisting in the later case with a square-pyramidal arrangement, react with one equivalent of CuCl to give the mononuclear heteroionic systems [M(L)Cl](CuCl₂) [L = PNHP, M = Pd (1a); L = P₃, M = Pd (2a), Pt (3a); L = NP₃, M = Pt (5a)]. The crystal structure of 3a confirms that Pt(II) retains the distorted square-planar geometry of 3 in the cation with P₃ acting as tridentate chelating ligand, the central P atom being trans to one chloride. The counter anion is a nearly linear dichlorocuprate(I) ion. However, the five-coordinate complexes [Pd(NP₃)Cl]Cl (4), [M(PP₃)Cl]Cl (M = Pd (6), Pt (7); PP₃ = tris[2-(diphenylphosphino)ethyl] phosphine) containing three fused five-membered chelate rings undergo a ring-opening by interaction with one (4, 6, 7) and two (6, 7) equivalents of CuCl with formation of neutral MCu(L)Cl₃ [L = NP₃, M = Pd (4a); L = PP₃, M = Pd (6a), Pt (7a)] and ionic [MCu(PP₃)Cl₂](CuCl₂) [M = Pd (6b), Pt (7b)] compounds, respectively. The heteronuclear systems were shown by ³¹P NMR to have structures where the phosphines are acting as tridentate chelating ligands to M(II) and monodentate bridging to Cu(I). Further additions of CuCl to the neutral species 6a and 7a in a 1:1 ratio resulted in the achievement of the ionic complexes 6b and 7b with ions as counter anions. It was demonstrated that the formation of heterobimetallic or just mononuclear mixed salt complexes was clearly influenced by the polyphosphine arrangement with the tripodal ligands giving the former compounds. However, complexes [M(NP₃)Cl]Cl constitute one exception and the type of reaction undergone versus CuCl is a function of the d⁸ metal centre.     

(Pyrazolylmethyl)pyridine platinum(II) and gold(III) complexes: Synthesis, structures and evaluation as anticancer agents

Reactions of 2-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L1), 2-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L2), 2-(3,5-di-tert-butylpyrazol-1-ylmethyl)pyridine (L3) and 2-(3-p-tolylpyrazol-1-ylmethyl)pyridine (L4) with K₂[PtCl₄] in a mixture of ethanol and water formed the dichloro platinum complexes [PtCl₂(L1)] (1), [PtCl₂(L2)] (2), [PtCl₂(L3)] (3) and [PtCl₂(L4)] (4). Complex 1, [PtCl₂(L1)], could also be prepared in a mixture of acetone and water. Performing the reactions of L2 and L3 in a mixture of acetone and water, however, led to C-H activation of acetone under mild conditions to form the neutral acetonyl complexes [Pt(CH₂COCH₃)Cl(L2)] (2a) and [Pt(CH₂COCH₃)Cl(L3)] (3a). The same ligands reacted with HAuCl₄ · 4H₂O in a mixture of ethanol and water to form the gold salts [AuCl₂(L1)][AuCl₄] (5) [AuCl₂(L2)][Cl] (6) [AuCl₂(L3)][Cl] (7) and [AuCl₂(L4)][AuCl₄] (8); however, with the pyrazolyl unit in the para position of the pyridinyl ring in 4-(3,5-dimethylpyrazol-1-ylmethyl)pyridine (L5), 4-(3,5-diphenylpyrazol-1-ylmethyl)pyridine (L6) neutral gold complexes [AuCl₃(L5)] (9) and [AuCl₂(L6)] (10) were formed; signifying the role the position of the pyrazolyl group plays in product formation in the gold reactions. X-ray crystallographic structural determination of L6, 2, 33a, 8 and 10 were very important in confirming the structures of these compounds; particularly for 3a and 8 where the presence of the acetonyl group confirmed C-H activation and for 8 where the counter ion is . Cytotoxicity studies of L2, L4 and complexes 1-10 against HeLa cells showed the Au complexes were much less active than the Pt complexes.     

Lewis acidity of platinum(II)-based Baeyer-Villiger catalysts: An electrochemical approach

The electrochemical behavior of the Pt(II)-based Baeyer-Villiger catalysts of the general formulae [Pt(μ-OH)(P^∩P)]₂(BF₄)₂ (P^∩P = dppe (1a), 2Fdppe (1 b), 4Fdppe (1c), dfppe (1d), dmpe (1e), depe (1f), dippe (1g), dtbpe (1h)) and [Pt(OH₂)₂(P^∩P)](OTf)₂ (P^∩P = dppe (2a), 2Fdppe (2b), 4Fdppe (2c), dfppe (2d)) is reported. They exhibit irreversible reduction processes whose potentials reflect the Lewis acidity of the metal centres, showing (for the aromatic diphosphine complexes) overall relations with the number of fluorine atoms, with J_Pt-P, with the ν(CN) coordination shift of a ligand isocyanide probe and with the catalytic activity. Single-crystal X-ray diffraction analyses were carried out for [Pt(μ-OH)(4Fdppe)]₂(BF₄)₂ (1c) and [Pt(μ-OH) (dippe)]₂(BF₄)₂ (1g).     

Synthesis of a new tetradentate bis(imino-phosphine) ligand and its complexation with copper(I) ions

Schiff base condensation of m-phenylenediamine with two equivalents of o-(diphenylphophino)benzaldehyde products the potentially tetradentate molecule 1,3-(Ph₂P(o-C₆H₄)CHN)₂C₆H₄ (1) in high yield. The reaction of 1 and [Cu(NCMe)₄]BF₄ affords the dinuclear complex [(1,3-(Ph₂P(o-C₆H₄)CHN)₂C₆H₄)₂Cu₂](BF₄)₂ (2) through coordination of the imino-phosphine groups. The structure of 2 has been determined by an X-ray diffraction study.     

The first pincer-aryl [M-(NCN)] complexes {M = Pd(II); Pt(II)} with chiral pyridine donors: Synthesis and catalytic activity in C-C bond formation

The first chiral bis(pyridine) N-C(H)-N pincer ligand, (5S,7S)-1,3-bis(6,6-dimethyl-5,6,7,8-tetrahydro-5,7-methanquinolin-2-yl)benzene (HL) has been synthesized and characterized by a thorough ¹H NMR analysis. Reaction of HL with K₂[PtCl₄] in acetic acid gives [Pt(L)Cl] (1), where L acts as a tridentate N-C-N pincer ligand. The analogous palladium(II) derivatives [Pd(L)Cl] (2), and [Pd(L)(OAc)] (3), were first prepared through a transmetalation reaction between Pd(OAc)₂ and the organomercury compound [Hg(L)Cl] (4). The structures of compounds 1 (Pt) and 2 (Pd), as determined by X-ray diffraction, are reported and compared. Compound 2 can also be obtained from Na₂[PdCl₄] and HL in refluxing acetic acid, i.e., under the same conditions used for compound 1. Apparently, this is the first palladium pincer derivative of a 1,3-bis(pyridyl)benzene ligand synthesized by direct C-H activation.The neutral complexes 1-3 are catalysts of modest activity, but devoid of enantioselectivity in the Heck reaction between iodobenzene and methyl acrylate and in the aldol condensation of benzaldehyde with methyl isocyanoacetate.     

Photoactive trans ammine/amine diazido platinum(IV) complexes

The synthesis and characterisation of eight new octahedral Pt^IV complexes of the type trans,trans,trans-[Pt(N₃)₂(OH)₂(NH₃)(Am)] where Am = methylamine (2), ethylamine (4), thiazole (6), 2-picoline (8), 3-picoline (10), 4-picoline (12), cyclohexylamine (14), and quinoline (16) are reported, including the X-ray crystal structures of complexes 2, 8, and 14 as well as that of two of the precursor Pt^II complexes (trans-[Pt(N₃)₂(NH₃)(methylamine)] (1) and trans-[Pt(N₃)₂(NH₃)(cyclohexylamine)] (13)). Irradiation with UVA light rapidly induces loss in intensity of the azide-to-Pt^IV charge-transfer bands and gives rise to photoreduction of platinum. These complexes have potential for use as photoactivated anticancer agents.     

Synthesis and structures of platinum(II) complexes with 5-ferrocenylpyrimidine

Reaction of platinum(II) salts with 5-ferrocenylpyrimidine (FcPM) afforded cis-[Pt(NH₃)₂(FcPM)₂](PF₆)₂ (1), trans-[Pt(NH₃)₂(FcPM)₂](PF₆)₂ (2), cis-[PtCl₂(FcPM)₂] (3), and cis-[PtCl₂(DMSO)(FcPM)] (4): their spectroscopic and electrochemical properties were investigated. Complexes 1 and 2 were structurally characterized by X-ray crystallography.     

Coordination polymers and monomers based on new aminocarboxylate ligands: A cadmium(II) polymer containing dimeric aqua-bridged cadmium complex governed by polymeric chain

The synthesis and characterization of novel coordination polymers [Co(HCCB)(H₂O)₂]_n (1), [Zn(HCCB)(H₂O)₂]_n (2), {[Cd(HCCB)₂]·0.5[Cd(μ-H₂O)(H₂O)₄]₂}_n (3) and [Cu(HCCB)(H₂O)₂]_n (4) based on 3-(carboxymethylamino)-4-chlorobenzoic acid (H₃CCB) and mononuclear complexes [Cu(HBCCB)(H₂O)]·H₂O (5), [Co(HBCCB)(H₂O)]·H₂O (6), [Zn(HBCCB)(H₂O)] (7) and [Cd(HBCCB)(H₂O)] (8) containing 3-bis(carboxymethylamino)-4-chlorobenzoic acid (H₃BCCB) have been described. The compounds under investigation have been characterized by elemental analyses, spectral studies and structures of 1-3 and 5 determined crystallographically. Structural data of 1 and 2 revealed that the deprotonated HCCB²⁻ bridges metal centers leading to a double stranded 1D chain. On the other hand, the HCCB²⁻ coordinated thorough carboxylate oxygen and amino nitrogen in 3 to afford a 1D chain whose charge neutrality is maintained by inclusion of aqua-bridged dimer [{Cd(μ-H₂O)(H₂O)₄}₂]⁴⁺. Strong Cu?Cl interaction (2.754 Å) in 5 imposes a coordination geometry that is half-way between the square planar and square pyramidal. The H₃CCB, H₃BCCB and 1-3 and 5 are fluorescent at rt. Thermal studies (TG and DSC) on 1-3 suggested higher stability of 2 relative to 1 and 3 [ΔH_f (kcal/mol), ΔS_f = 152.17, 0.60, 1; 195.56: 0.86, 2; 69.33:0.36, 3].     

Synthesis and cyclization reactions of platinum(II)-coordinated arsonium-substituted phenyl isocyanides, o-(IR3As-CH2)C6H4NC

The arsonium-substituted isocyanides, o-(I⁻⁺R₃AsCH₂)C₆H₄NC (AsR₃=AsPh₃, L₁; AsMePh₂, L₂; AsMe₂Ph, L₃), were prepared by reaction of o-(chloromethyl)phenyl isocyanide, o-(CH₂Cl)C₆H₄NC, with a slight molar stoichiometric amount of the arsine in the presence of a 3-fold excess of NaI in acetone at room temperature. The isocyanides L₁-L₃ coordinate to some Pt(II) complexes such as trans-[PtX{o-(I⁻⁺R₃AsCH₂)C₆H₄NC}(PPh₃)₂] [BF₄] (AsR₃=AsPh₃, 1; AsMePh₂, 2; AsMe₂Ph, 3; X=Cl, I) and [PtX{o-(I⁻⁺R₃AsCH₂)C₆H₄NC}(Ph₂PCHCHPPh₂)] [BF₄] (AsR₃=AsMePh₂, 4; X=Cl, I). Complexes 2-4 are converted in CH₂Cl₂ at room temperature in the presence of NEt₃ to the corresponding indolidin-2-ylidene derivatives trans-[PtX{(AsR₃)}(PPh₃)₂]BF₄] (AsR₃=AsPh₃, 5; AsMePh₂, 6; AsMe₂Ph, 7) and [PtX{(AsMePh₂)}(Ph₂PCHCHPPh₂)][BF₄] (8).     

Interaction of Pt(II) and Pd(II) complexes of terpyridine with 1-methylazoles: A combined experimental and density functional study

The synthesis and characterization of several complexes of the composition [{M(terpy)}_n(L)](ClO₄)_m (M = Pt, Pd; L = 1-methylimidazole, 1-methyltetrazole, 1-methyltetrazolate; terpy = 2,2′:6′,2″-terpyridine; n = 1, 2; m = 1, 2, 3) is reported and their applicability in terms of a metal-mediated base pair investigated. Reaction of [M(terpy)(H₂O)]²⁺ with 1-methylimidazole leads to [M(terpy)(1-methylimidazole)](ClO₄)₂ (1: M = Pt; 2: M = Pd). The analogous reaction of [Pt(terpy)(H₂O)]²⁺ with 1-methyltetrazole leads to the organometallic compound [Pt(terpy)(1-methyltetrazolate)]ClO₄ (3) in which the aromatic tetrazole proton has been substituted by the platinum moiety. For both platinum(II) and palladium(II), doubly metalated complexes [{M(terpy)}₂(1-methyltetrazolate)](ClO₄)₃ (4: M = Pt; 5: M = Pd) can also be obtained depending on the reaction conditions. In the latter two compounds, the [M(terpy)]²⁺ moieties are coordinated via C5 and N4. X-ray crystal structures of 1, 2, and 3 are reported. In addition, DFT calculations have been carried out to determine the energy difference between fully planar [Pd(mterpy)(L)]²⁺ complexes Ip-IVp (mterpy = 4′-methyl-2,2′:6′,2″-terpyridine; L = 1-methylimidazole-N3 (I), 1-methyl-1,2,4-triazole-N4 (II), 1-methyltetrazole-N3 (III), or 3-methylpyridine-N1 (IV)) and the respective geometry-optimized structures Io-IVo. Whereas this energy difference is larger than 70 kJ mol⁻¹ for compounds I, II, and IV, it amounts to only 0.8 kJ mol⁻¹ for the tetrazole-containing complex III, which is stabilized by two intramolecular C-H?N hydrogen bonds. Of all complexes under investigation, only the terpyridine-metal ion-tetrazole system with N3-coordinated tetrazole appears to be suited for an application in terms of a metal-mediated base pair in a metal-modified oligonucleotide.     

Electrochemical behavior of S,S-bridged adducts of square planar metalladithiolene complexes [M(S2C2Ph2)2](M=Ni, Pd, and Pt)

The electrochemical behavior of the S,S^′-bridged adducts of square planar metalladithiolene complexes was investigated by using cyclic voltammetry and electrochemical spectroscopies (visible, near-IR, and ESR). The norbornene-bridged S,S^′-adduct [Ni(S₂C₂Ph₂)₂(C₇H₈)] (2a; C₇H₈=norbornene) formed by [Ni(S₂C₂Ph₂)₂] (1a) and quadricyclane (Q) was dissociated by an electrochemical reduction, and anion 1a⁻ and norbornadiene (NBD) were formed. Q was isomerized to NBD in the overall reaction. The o-xylyl-bridged S,S^′-adduct [Ni(S₂C₂Ph₂)₂(CH₂)₂(C₆H₄)] (3a; (CH₂)₂(C₆H₄)=o-xylyl) was also dissociated by an electrochemical reduction, and this reaction gave the o-xylyl radical (o-quinodimethane). The reduction of complex 3a in the presence of excess o-xylylene dibromide underwent the catalytic formation of o-quinodimethane. The butylene-bridged S,S^′-adduct [Ni(S₂C₂Ph₂)₂(CH₂)₄] (4a; (CH₂)₄=butylene) was stable on an electrochemical reduction. The lifetimes of reduced species of these adducts 2a-4a were influenced by the stability of the eliminated group (stability: NBD > o-xylyl radical (o-quinodimethane) > butylene radical). Therefore, the reduced species are stable in the sequence 4a⁻ > 3a⁻ > 2a⁻. Although the palladium complex [Pd(S₂C₂Ph₂)₂] (1b) was easier to reduce than the nickel complex 1a or the platinum complex [Pt(S₂C₂Ph₂)₂] (1c), their S,S^′-adducts were easier to reduce in the order of Ni adduct > Pd adduct > Pt adduct.     

Mono- and dinuclear (o-thioetherphenolato)-copper(II) complexes. Structural models for galactose oxidase

Three new o-thioetherphenol ligands have been synthesized: 1,2-bis(3,5-di-tert-butyl-2-hydroxyphenylsulfanyl)ethane (H₂bse), 1,2-bis(3,5-di-tert-butyl-2-hydroxyphenylsulfanyl)benzene (H₂bsb), and 4,6-di-tert-butyl-2-phenylsulfanylphenol (Hpsp). Their complexes with copper(II) were prepared and investigated by UV-Vis-, EPR-spectroscopy; their electro- and magnetochemistry have also been studied: [Cu^II(psp)₂] (1), [Cu^II₂(bse)₂] (2), [Cu^II₂(bsb)₂] (3), [Cu^II(bsb)(py)₂] (4). The crystal structures of the ligands H₂bse, H₂bsb, Hpsp and of the complexes 1, 2, 3, 4 have been determined by X-ray crystallography.     

Reactivity of the ligand bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]ether (L1) with Pd(II) and Pt(II): crystal structure of cis-[PtCl2(L1)]

The coordination chemistry of the ligand bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]ether (L₁) was tested in front of Pd(II) and Pt(II). Complexes cis-[MCl₂(L₁)] (M=Pd(II) and Pt(II)) were obtained, due to the chelate condition of the ligand and the formation of a stable 10-membered ring. The crystal structure of cis-[PtCl₂(L₁)] was resolved by X-ray diffraction. Treatment of [PdCl₂(L₁)] or [Pd(CH₃CN)₄](BF₄)₂ with AgBF₄ in the presence of L₁ gave the complex [Pd(L₁)₂](BF₄)₂. The initial cis-[PdCl₂(L₁)] was recovered by reacting [Pd(L₁)₂](BF₄)₂ with an excess of NEt₄Cl. Reaction of [Pt(CH₃CN)₄](BF₄)₂ (generated in situ from [PtCl₂(CH₃CN)₂] and AgBF₄ in acetonitrile) with ligand L₁ yields complex [Pt(L₁)₂](BF₄)₂.     

Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine

Three platinum-chloroquine complexes, trans-Pt(CQDP)₂(I)₂ [1], trans-Pt(CQDP)₂(Cl)₂ [2] and trans-Pt(CQ)₂(Cl)₂ [3], were prepared and their most probable structure was established through a combination of spectroscopic analysis and density functional theory (DFT) calculations. Their interaction with DNA was studied and their activity against 6 tumor cell lines was evaluated. Compounds 1 and 2 interact with DNA primarily through electrostatic contacts and hydrogen bonding, with a minor contribution of a covalent interaction, while compound 3 binds to DNA predominantly in a covalent fashion, with weaker secondary electrostatic interactions and possibly hydrogen bonding, this complex also exerted greater cytotoxic activity against the tumor cell lines.     

Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin

The interactions of π-arene-Ru(II)-chloroquine complexes with human serum albumin (HSA), apotransferrin and holotransferrin have been studied by circular dichroism (CD) and UV-Visible spectroscopies, together with isothermal titration calorimetry (ITC). The data for [Ru(η⁶-p-cymene)(CQ)(H₂O)Cl]PF₆ (1), [Ru(η⁶-benzene)(CQ)(H₂O)Cl]PF₆ (2), [Ru(η⁶-p-cymene)(CQ)(H₂O)₂][PF₆]₂ (3), [Ru(η⁶-p-cymene)(CQ)(en)][PF₆]₂ (4), [Ru(η⁶-p-cymene)(η⁶-CQDP)][BF₄]₂ (5) (CQ: chloroquine; DP: diphosphate; en: ethylenediamine), in comparison with CQDP and [Ru(η⁶-p-cymene)(en)Cl][PF₆] (6) as controls demonstrate that 1, 2, 3, and 5, which contain exchangeable ligands, bind to HSA and to apotransferrin in a covalent manner. The interaction did not affect the α-helical content in apotransferrin but resulted in a loss of this type of structure in HSA. The binding was reversed in both cases by a decrease in pH and in the case of the Ru-HSA adducts, also by addition of chelating agents. A weaker interaction between complexes 4 and 6 and HSA was measured by ITC but was not detectable spectroscopically. No interactions were observed for complexes 4 and 6 with apotransferrin or for CQDP with either protein. The combined results suggest that the arene-Ru(II)-chloroquine complexes, known to be active against resistant malaria and several lines of cancer cells, also display a good transport behavior that makes them good candidates for drug development.     

Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties

A series of new silver(I) saccharinate (sac) complexes, [Ag₂(sac)₂(μ-dppm)H₂O]·H₂O (1), {[Ag₂(μ-sac)₂(μ-dppe)]·3H₂O·CH₂Cl₂} _n (2), [Ag₂(μ-sac)₂(μ-dppp)] _n (3), and [Ag(sac)(μ-dppb)] _n (4) [dppm is 1,1-bis(diphenylphosphino)methane, dppe is 1,2-bis(diphenylphosphino)ethane, dppp is 1,3-bis(diphenylphosphino)propane, and dppb is 1,4-bis(diphenylphosphino)butane], have been synthesized and characterized by C, H, N elemental analysis, IR spectroscopy, ¹H NMR, ¹³C NMR, and ³¹P NMR spectroscopy, electrospray ionization mass spectrometry, and thermogravimetry–differential thermal analysis. Single-crystal X-ray studies show that the diphosphanes act as bridging ligands to yield a dinuclear complex (1) and one-dimensional coordination polymers (2 and 4), whereas the sac ligand adopts a μ₂-N/O bridging mode in 2, and is N-coordinated in 1 and 4. The interaction of the silver(I) complexes with fish sperm DNA was investigated using UV–vis spectroscopy, fluorescence spectroscopy, and agarose gel electrophoresis. The binding studies indicate that the silver(I) complexes can interact with fish sperm DNA through intercalation, and complexes 1 and 3 have the highest binding affinity. The gel electrophoresis assay further confirms the binding of the complexes with the pBR322 plasmid DNA. The minimum inhibitory concentrations of the complexes indicate that complex 1 exhibits very high antibacterial activity against standard bacterial strains of Escherichia coli, Salmonella typhimurium, and Staphylococcus aureus, being much higher than those of AgNO₃, silver sulfadiazine, ciprofloxacin, and gentamicin. Moreover, complexes 1–3 exhibit very high cytotoxic activity against A549 and MCF-7 cancer cell lines, compared with AgNO₃ and cisplatin. The bacterial and cell growth inhibitions of the silver(I) complexes are closely related to their DNA binding affinities.     

Methimazole complexes of platinum(II): Synthesis, characterization and redox behavior

A variety of platinum(II) complexes of methimazole (2-mercapto-1-methylimidazole; HImS = neutral form and ImS = thiolate form), coordinated in both thione and thiolate forms, have been isolated by reacting methimazole with [PtCl(terpy)]Cl (terpy = 2,2′:6′,2″ terpyridine), [PtCl₂(bipy)] (bipy = bipyridine), [PtCl₂(o-phen)] (o-phen = o-phenanthroline), [PtCl₂(CH₃CN)₂] and [PtCl₂(COD)] (COD = 1,5-cyclooctadiene). These complexes were characterized by electronic absorption, IR and NMR (¹H, ¹³C, ¹⁹⁵Pt) spectroscopies. Molecular structure of [Pt(bipy)(HImS)₂]Cl₂·3H₂O (3a·3H₂O) has been established by single crystal X-ray crystallography. Platinum thiolate complex, [Pt(ImS)₂(HImS)₂] (5), could be obtained by treatment of [Pt(HImS)₄]Cl₂ with sodium methoxide in methanol. The solution of 5 in organic solvents yielded bi- and tri-nuclear platinum complexes. The effect of diimine ligands on oxidation of methimazole moiety in the complexes has been studied by electrochemical oxidation and pulse radiolytic oxidation employing specific one-electron oxidant, radical.     

Iron Se-bonded mono-selenocarbonates CpFe(CO)2SeCO2R: the first selenocarbonate complexes

The reactivity of the iron selenide complex (μ-Se)[CpFe(CO)₂]₂ toward chloroformates, ROCOCl, has been studied and the products CpFe(CO)₂SeCO₂R [R=Me (1), Et (2), iso-Bu (3), Ph (4), 2-C₆H₄Cl (5), 4-C₆H₄Cl (6), and 4-C₆H₄NO₂ (7)] have been obtained. The novel complexes, 1-7, have been characterized by elemental analyses, IR and ¹H NMR spectroscopy. The solid state structure of CpFe(CO)₂SeCO₂Et, 2, was determined by an X-ray crystal structure analysis.